Transformational Health experts and industry thought leaders lead a webinar on how deploying data-driven approach is necessary to track analytics and test utilization parameters
SANTA CLARA, Calif., Feb. 19, 2019 /PRNewswire/ — Direct-to-consumer (DTC) testing is on a high rise after the Food and Drug Administration (FDA) announced the premarket approval process for genetic health risk tests. Given the reimbursement cuts, it is essential to understand how this can impact the revenue-generating abilities of clinical laboratories and what strategies they can take now to keep the business profitable.
Frost & Sullivan invites you to join our Transformational Health team, for the webinar “Future of Clinical Laboratories – Winning Strategies & Growth Opportunities,” on Tuesday, March 5, 2019, from 1:00 PM to 2:00 PM Eastern Time. Our global life sciences expert Divyaa Ravishankar, Industry Principal; and Kyle Fetter, Executive Vice President & General Manager of Diagnostic Services at XIFIN, will provide insights into some winning strategies that can help laboratories combat the deep cuts issued by the Protecting Access to Medicare Act (PAMA) in the United States, and the clinical lab scenario in Europe and Canada. As the market is witnessing heavy consolidation, both hospitals and laboratories are adopting new business models and diversifying their revenue channel through acquisitions.
“Given the reimbursement cuts, it is important to understand how this can impact the revenue generating abilities for clinical laboratories and what strategies can they take now to keep the business profitable,” explains Ravishankar. “As laboratories look to increase efficiency in testing, deploying data-driven approach is necessary to track analytics and test utilization parameters.”
For more information and to register for the webinar, please visit http://frost.ly/35u.
Key benefits of attending this webinar:
- Discover the outlook of the clinical laboratories market in the United States, Europe, APAC, and the key players.
- Understand what is driving business for clinical laboratories and what will change in the future.
Learn how are clinical laboratories adjusting to the declining reimbursement situation.
Gain insight into ways a data-driven approach can help laboratories increase efficiency.
Better understand how blockchain applies in the world of clinical laboratory services testing.
The event will also be recorded and available for on-demand viewing at http://frost.ly/1ti.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Frost & Sullivan
+1 (210) 348 1012